Qiang Wu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Diagnostic accuracy of deep learning models for colorectal cancer detection in histopathological whole-slide images: a systematic review and diagnostic test accuracy meta-analysis.
Journal: Frontiers in oncology
Published: May 19, 2026
Association between academic burnout exposure patterns and symptoms of depression and anxiety among international students in China.
Journal: BMC public health
Published: January 20, 2026
ARNTL2 regulated the oncogene c-myc and promoted the progression of esophageal cancer through activating ANXA2 transcription.
Journal: Cancer biology & therapy
Published: November 17, 2025
The role and mechanisms of T cell immunity in atherosclerosis: a pathogenic and therapeutic perspective.
Journal: The American journal of the medical sciences
Published: August 16, 2025
Serine/arginine-rich splicing factor 1 inhibits ferroptosis and promotes glycolysis in endometrial cancer via activating mTOR and β-catenin.
Journal: Pathology, research and practice
Published: June 18, 2025
PPARG-FABP4 regulates PI3K/Akt pathway to promote lung cancer-associated macrophage endoplasmic reticulum stress-mediated CD36 expression and affects lung squamous cell carcinoma metastasis.
Journal: Cellular signalling
Published: June 18, 2025
Integrated single-cell and transcriptomic analysis of bone marrow-derived metastatic neuroblastoma reveals molecular mechanisms of metabolic reprogramming.
Journal: Scientific reports
Published: May 20, 2025
Identification of PDGFRB as a prognostic immune-related biomarker in gastric cancer through bioinformatics and clinical analysis.
Journal: Translational cancer research
Published: April 23, 2025
Zinc Finger Protein 536 is a Potential Prognostic Biomarker that Promotes Neuroblastoma Progression via VEGFR2-PI3K-AKT Pathway.
Journal: Current cancer drug targets
Published: May 24, 2024
CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma.
Journal: Anti-cancer drugs
Published: May 15, 2024
Last Updated: 09/26/2026